Dr. Marty Makary on estrogen patch shortages and FDA’s role
FDA Commissioner Dr. Marty Makary discusses the demand surge and shortages of estrogen patches. He explains the FDA’s choice to take away the black field warning, resulting in elevated demand, and its influence on girls’s well being and
Support Greater and Subscribe to view content
This is premium stuff. Subscribe to read the entire article.
Login if you have purchased
